IRINOTECAN Accord 500 mg/25ml flac 25 ml
7680667660040
CH-66766
L01CE02
07.16.1.
1 / 3
google
Details
- Product number
- 6676604
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- irinotecani hydrochloridum trihydricum 500 mg, acidum lacticum, sorbitolum 1125 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 25 ml corresp. natrium max. 2.01 mg.
Articles (1)
Irinotecan Accord 500 mg/25 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1125.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 405.70
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2018
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66766
- Drug name
- Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CE02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/09/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IRINOTECAN Accord 500 mg/25ml flac 25 ml
- Description (DE)
- IRINOTECAN Accord 500 mg/25ml Durchstf 25 ml
- Market launch
- 24/09/2018
- Narcotic (BTM)
- No